Algenuity Newsletter - Spring 2019

algenuity • May 01, 2019

Welcome to Algenuity’s spring newsletter!

A quick update on what’s going on at Algenuity
To subscribe to our newsletter, sign up at this link: http://eepurl.com/cTiWlH 

Successful grant outcome with aquaculture feed applications

Our three-year Innovate UK-funded PALM-UK (Pilot Algal Manufacturing in the UK) grant had its close out meeting on Thursday 18th April 2019 with two of our partners, Plymouth Marine Laboratory and Rothamsted Research. One of the successful outcomes was the development of a multi-functional microalgal strain featuring omega-3 polyunsaturated fatty acids and recombinant phytase and lactoferrin to benefit fish health. Read the full article or summary showcasing this work with SPAROS, a spin-off company of the Centre of Marine Sciences of Algarve (CCMAR) at the University of Algarve, Portugal, for International Aquafeed magazine.

Sharing our passion

ACI’s 9th European Algae Industry Summit from the 10th-11th of April in Lisbon, Portugal, was an excellent opportunity to connect with other professionals in the algae industry, to share our passion for ongoing developments, and to discuss our recent work on multi-parameter and design of experiments optimisation using our Algem technology. We are excited to be attending VitaFoods Europe, the flagship nutraceutical conference, in Geneva, Switzerland, from the 7th-8th May 2019. Check out our events schedule for the year here.

Supporting great science

Our team member Denise enjoys supporting the scientists at Algenuity, and has the very important task of keeping the team in check when it comes to lab tidiness! Read more about Denise’s role and how she fits into the Algenuity family.

Check out more of our publications

World Fishing and Aquaculture has published an article on our work for aquaculture biotechnology company MicroSynbiotiX. Through proof of concept work, we helped to validate genetically modified microalgae for use as a novel, cost-effective oral delivery platform for vaccine administration to aquaculture populations. This work will help to protect species against common bacterial infections and reduce antibiotic use, ultimately saving the industry billions of dollars by preventing loss of stock. Find the full article here.

Stay tuned for our article in Laboratory News , discussing the unique potential of microalgae in synthetic biology applications. Algae is an effective alternative to well-established platform organisms – such as yeast and bacteria – and we are investigating how it can benefit sustainability, scalability, and productivity in novel commercial projects.

That's it for now!

Did you like what was in here? Do you have a story or paper to share? Please send your feedback to jcp@algenuity.com

We are also looking for users to interview with their Algem experiences. Send an email to the address above!

See you in about three months!

To subscribe to our newsletter, sign up at this link: http://eepurl.com/cTiWlH 
Share by: